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Summary 
The VLA/integrins are a family of heterodimeric adhesion receptors  shown to be involved in 
cell-to-cell and cdl-to-extracellular matrix (ECM) interactions. Given recent evidence that VLA 
molecules can synergize with the CD3/T cell receptor (TCR) pathway to activate T  calls, it 
is important to identify biochemical event(s) generated by these molecules. Here, we report that 
the engagement of VLA-4 on T  cells with specific antibodies or its ligand activates protein- 
tyrosine kinase (FIX) activity as detected by antiphosphotyrosine immunoblotting. The crosslinking 
of VLA-/31 (CD29) with a specific monoclonal antibody (mAb) (anti-4B4)  plus anti-mouse 
immunoglobulin resulted in the rapid tyrosine phosphorylation of a 105-kD  protein (ppl05) 
in the human T cell line H9, as well as in peripheral resting T  cells. The increase in tyrosine 
phosphorylation of ppl05 was specifically mediated by VLA-4, since mAbs against or4, but not 
against other VLA c~ chains,  could induce this phosphorylation. In addition, the binding of 
T  cells with the CS1 alternatively  spliced segment of fibronectin (the binding site recognized 
by VLA-4) induced ppl05 tyrosine phosphorylation. Crosslinking the CD3 complex or VLA-4 
molecules with  mAbs  demonstrated that  each  of these  molecules stimulated the  tyrosine 
phosphorylation of unique sets of proteins with different kinetics,  suggesting that these two 
receptor systems are coupled to distinct PTKs. Since tyrosine phosphorylation of cellular proteins 
has been shown to be a crucial biochemical event in cell growth, our findings suggest that the 
induction of ppl05 tyrosine phosphorylation via VLA-4 may play a role in the transduction of 
activation signals through this molecule. 
~  hesion molecules on T  cells have attracted increasing 
attention because of their diverse roles in differentia- 
tion,  recirculation,  antigen  recognition,  activation,  and 
proliferation (1, 2). According to their basic structure, lym- 
phocyte adhesion molecules have been classified into three 
broad categories: the immunoglobulin, integrin, and selectin 
families (1). The VLA antigens constitute the B1 integrin 
subfamily (3), and are one of the major adhesion receptors 
expressed by T cells. They are transmembrane glycoproteins 
consisting of a common/31 subunit (CD29) noncovalently 
associated with distinct c~ chains to form different heterodi- 
mers (2). The VLA proteins function as cell surface receptors 
mediating cell-to-cell and cell-to-extracellular matrix protein 
(ECM) 1 adhesive interactions. On resting CD4 § T cells, the 
VLA/CD29  antigens  are  preferentially  expressed  on  the 
CD45RO +  CD45RA-  helper/inducer (memory) subset (4, 
5). Presumably,  VLA molecules allow these helper cells to 
interact effectively with the surrounding ECM or aid migra- 
1Abbreviations used in  this paper: ECM,  extracellular  matrix;  FN, 
fibronectin;  PLC, phospholipase  C; FFK, protein-tyrosine  kinase; RSV, 
R.ous sarcoma virus. 
tion into tissues. Recent studies have clearly shown that the 
VLA molecules not only mediate T  cell adhesion, but can 
synergize with the CD3/TCR pathway to promote T  cell 
proliferation (6-11). Coimmobilization of ligand proteins for 
the VLA receptor family and submitogenic  doses of anti-CD3 
results in strong T  cell proliferation through at least  five 
receptor/ligand interactions:  VLA-3/collagen, VLA-4/fibro- 
nectin (FN)  (CS1 region),  VLA-4/VCAM-1, VLA-5/FN 
(RGD sequence), and VLA-6/laminin. Furthermore, it has 
been proposed that the expression of FN receptors (VLA-4 
or VLA-5) on a subpopulation of thymocytes plays a role in 
thymic differentiation (12, 13). While the interaction of VLA 
molecules with ECM or cell surface molecules may have a 
variety of biological effects on T cells, the nature of the signals 
generated by the engagement of the VLA with their ligands 
is still far from clear. 
Recent studies have documented that tyrosine phosphory- 
lation on cellular proteins is an early and obligatory event 
in the activation of T cells (14-20). Ligation of the CD3/TCR 
complex by anti-CD3 antibody induces rapid tyrosine phos- 
phorylation of several intracellular  proteins, including the 
CD3-associated ~" chain (15, 16) and phospholipase C (PLC)- 
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phosphate  and  cytosolic  Ca  2+  concentrations.  Moreover, 
protein-tyrosine  kinase  (PTK)  inhibitors  can  prevent 
TCR/CD3-mediated  PLC  activation  and  cytosolic  Ca  2§ 
influx (19, 20). These results suggest that PTKs are dosdy 
associated with signaling through the TCR/CD3 complex 
and regulate subsequent events that ultimately lead to T cell 
proliferation.  It is not known which PTKs are responsible 
for these early phosphorylation events. However, p56  ~k and 
p59/~" have  been shown  to be associated with  CD4/CD8 
(21, 22) and the TCR/CD3 complex (23), respectively, and 
are considered to be likely candidates.  There also have been 
reports (24-27) suggesting that PTK activation may play a 
role in the cell adhesion process. In Rous sarcoma virus (RSV)- 
transformed cells, the FN receptor (integrin),  as well as sev- 
eral cytoskeletal  protdns that  are  closely  linked  to  FN receptors, 
were shown to  be hyperphosphorylated on tyrosine  residues 
(24).  In addition,  it  was demonstrated that  several  src  family 
PTKs such as  c-yes,  c-src,  and c-lyn  were enriched in ceil-to- 
cell  adhesion  junctions  in  normal adult  tissues  where the  level 
of  tyrosine  phosphorylation is  devated (27).  However, direct 
evidence showing that PTK activation is functionally assodated 
with  signal  transduction  through  the  VLA  molecules  is 
lacking. 
Given the costimulatory signals delivered when VLA and 
CD3  antigens  are simultaneously  triggered,  we examined 
whether the perturbation of VLA molecules could activate 
tyrosine kinases.  We report here that  engagement  of VLA 
molecules by specific antibodies, or by their ligands, rapidly 
stimulated  tyrosine phosphorylation  on a  105-kD  protein 
(ppl05) in both the H9 T cell line and peripheral resting T 
cells. The induction of ppl05 tyrosine phosphorylation ap- 
pears to be specific for the VLA-4 molecule.  Finally,  VI'K 
activation stimulated via VLA-4 was regulated independently 
from  that  associated  with  T  cell  activation  through  the 
CD3/TCK  pathway. 
Materials  and Methods 
mAbs  and Reagents.  mAbs  reactive with  CD3  (RW24B6, 
IgG2b), CDlla/LFA-1 (2F12, IgG1), CD20 (B1, IgG2a), CD29/ 
VLA-B1 (4B4, IgG1), CD45 (GAP 8.3, IgG2a), CD56 (NKH1, 
IgG1), MHC class I (W6/32, IgG2a), and MHC class II (9-49, 
IgG2a),  were used in our study.  Their production  and charac- 
terization  have been  described  elsewhere  (4,  28-30).  Anti- 
CDw49a/VLA-1 (TS2/7, IgG1) was kindly provided by Dr. Martin 
E. Hemler  (Dana-Farber Cancer Institute,  Boston,  MA).  mAbs 
against CDw49b/VLA-2 (G19, IgG1) and CDw49f/VLA-6 (GoI-I3, 
rat  IgG2a) were obtained from AMAC,  Inc. (Westbrook,  ME). 
Anti-CDw49c/VLA-3 (P1BS, IgG2a) was obtained from Oncogene 
Science, Inc. (Manhasset, NY). Anti-CDw49d/VLA-4 (8F2, IgG1), 
and anti-CDw49e/VLA-5  (2I-I6, IgG1) were developed in our lab- 
oratory and described previously (6, 10). Antiphosphotyrosine  an- 
tibody (4G10, IgG2b) and genistein were purchased from Upstate 
Biotechnology, Inc. hboratories (Lake Placid, NY). Affinity-purified 
goat anti-mouse Ig was obtained from Tago, Inc. (Burlingame, 
CA). Human FN was obtained from Telios Pharmaceuticals, Inc. 
(San Diego, CA). BSA, transferrin, and soybean lipids used in the 
serum free medium were from Boehringer Mannheim  Biochem- 
icals (Mannheim,  Germany). IMDM, Tyr(P), Ser(P), and Thr(P) 
were from Sigma Chemical Co. (St. Louis, MO). The synthetic 
CS1 peptide (CDELPQLVTLPHPNHLGPEILDVPST)  that con- 
tains residues 1-25 of the type III connecting segment of FN and 
its rabbit lgG-conjugated  form (31) was kindly provided by Dr. 
Martin J. Humphries  (Manchester University, England), and Dr. 
Kenneth  M.  Yamada (National  Institute  of Dental  Research, 
Bethesda, MD). 
T Cells.  The human T cell lines H9, Jurkat,  HPB-ALL, and 
MOLT4, were used in our study. Cell lines were cultured in RPMI 
1640 containing  10% heat-inactivated FCS, and 2 mM glutamine. 
PBMC were separated from whale blood by centrifugation  over 
Ficoll-Hypaque. Monocytes were depleted by adherence to plastic 
dishes for at least 1 h.  Nonadherent  cells were then depleted of 
B cells, NK cells, and residual monocytes with negative selection 
with anti-CD20,  anti-h,  and anti-CD56  using goat anti-mouse 
immunomagnetic Dyn  _abe~__s  M-450 (Dynal Inc., Great Neck, NY). 
The resulting cells were used as resting  T  cells. 
Stimulation of Cells and Preparation of Cell Lysates.  Cells were 
washed three times and resuspended in Iscove's serum-free media 
and dispensed into 1.5-ml Eppendorf tubes with 2.5-5.0  ￿  10  ~ 
cells/1 ml/sample. The samples were either left as controls or in- 
cubated with saturating concentrations of mAb (10 #g/ml) for 15 
rain at 4"C, washed once with cold media, and then  incubated 
with 200/~1 of media containing anti-mouse Ig (10 t~g/ml) at 37~ 
for different time periods. The reactions were terminated by the 
addition of 1 ml of stop solution (cold PBS containing 5 mM ~, 
10 mM NaF, 10 mM Na pyrophosphate,  and 0.4 mM Na vana- 
date). Cells were pelleted and then solubilized in lysis buffer (1% 
NP-40, 150 mM NaC1, 50 mM Tr/s HC1, pH 8.0, 5 mM EDTA, 
1 mM PMSF, 10 mM iodoacetamide, 10 mM NaF, 10 mM Na 
pyrophosphate, and 0.4 mM Na vanadate) for 15 min on ice. After 
removing insoluble material by centrifugation  at 14,000 rpm for 
10 min, supernatants were subjected to electrophoresis according 
to the method described below. In some experiments, cells were 
stimulated with CS1 peptide/rabbit  IgG conjugate  immobilized 
on six-well cultured plates (Costar Corp., Cambridge, MA). Prep- 
aration of plates coated with the CS1/IgG conjugate was described 
previously (10). Cells were cultured in these wells for the period 
indicated, followed by addition of cold stop solution, and then solu- 
bilized by lysis buffer as described above. 
Electraphoresis and lmraunoblotting.  Cell lysates were separated 
on a 7.5% SDS-polyacrylamide gel under reducing conditions ac- 
cording to the method of Laemmli, (31a) and then electrophoreti- 
cally transferred  to nitrocellulose membrane,  and blotted using 
l~I-labeled antiphosphotyrosine  antibody (aPT) using  methods 
described elsewhere (32). Affinity-purified cxPT was iodinated to 
a specific radioactivity of 10-20 #Ci/#g protein using Iodobeads 
(Pierce Chemical Co., Rockford, IL). Autoradiographic exposures 
were performed using Kodak XAR film (Eastman Kodak, Roch- 
ester, NY). 
Results 
Crosslinking VLA Molecules with anti-CD29 mAb Stimulates 
Tyrosine Phosphorylation of a 105-kD Protein in the I"19 T  Cell 
Line  We have previously shown that crosslinking VLA mol- 
ecules with anti-VLA-:/1  (anti-CD29)  antibody, as well as 
immobilized FN, are comitogenic in CD3-dependent CD4 + 
cell proliferation (33). Therefore, to examine whether hga- 
tion of VLA molecules had an effect on tyrosine phosphory- 
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tion of several T  cell lines before and after the crosslinking 
of VLA molecules with the anti-CD29 mAb, anti-4B4. T 
cells were incubated with anti-CD29 and then incubated with 
prewarmed (37~  media containing goat anti-mouse Ig for 
different time periods (1-60 rain).  Cell lysates from anti- 
CD29-treated and untreated cells were run on SDS-PAGE, 
and proteins phosphorylated on tyrosine residues were de- 
tected by immunoblotting with o~PT. As shown in Hg.  1, 
anti-CD29 induced a significant increase in the tyrosine phos- 
phorylation of a protein with an apparent molecular mass 
of 105 kD (ppl05) in H9 cells. A faint increase in tyrosine 
phosphorylation on ppl05 could be seen 1 min after anti- 
CD29 crosslinking, and reached a maximal level after 5-10 
min. The level of phosphoryhtion  declined slightly after 30-60 
min, but was still significantly increased for at least 3 h (data 
not shown). Because of the high level of tyrosine phosphory- 
lation after anti-CD29 crosslinking, ppl05 was readily de- 
tectable  after  relatively  brief  autoradiographic  exposures 
(1-2 h). Under these conditions, ppl05 was the only tyrosine- 
phosphorylated protein observed in H9 cell lysates (Fig.  1). 
Occasionally,  ppl05 appeared to be a doublet, with the ap- 
pearance of a faint additional band at a slightly higher posi- 
tion.  Other  phosphorylated proteins became visible  after 
prolonged exposure. However, no difference in the degree 
of tyrosine phosphorylation of these bands was observed be- 
fore and after treatment with anti-CD29. Despite the high 
degree of CD29 expression on a number of other T cell lines 
including  Jurkat, HPB-ALL, and MOLT-4, only H9 cells ex- 
hibited phosphorylation of this 105 kD molecule after anti- 
CD29 crosslinking (data  not shown). 
Next, we examined whether the induction of tyrosine phos- 
phorylation of ppl05 was specific for anti-CD29. As shown 
in Fig. 2, although anti-CD29 crosslinking clearly induced 
ppl05 tyrosine phosphorylation in H9 cells (lanes 1 and 2), 
the crosslinking of control antibodies ~gainst surface mole- 
cules with similar levels  of expression, including LFA-1 (2F12), 
MHC  class  I  molecule  (W6/32),  and  CD45  leukocyte 
common antigen (GAP 8.3), failed to stimulate ppl05 phos- 
phorylation (lanes 3-5).  Anti-CD29  alone,  without anti- 
mouse Ig, elicited  a minimal response (lane 6), suggesting 
that crosslinking or coclustering of VLA antigens was neces- 
sary for the induction of ppl05 tyrosine phosphorylation. 
To further confirm the specificity  of our observation, we 
showed that preincubation of the immunoblot with excess 
amounts of phosphotyrosine (10/~M), but not phosphoserine 
or phosphothreonine, blocked the detection of ppl05 (Hg. 
3 A). In addition, pretreatmeut of cells with genistein, a po- 
tent PTK inhibitor, inhibited ppl05 phosphoryhtion  in a dose- 
dependent fashion (Hg. 3 B). The viability of H9 cells was 
not affected  over this range of genistein concentration. Pretreat- 
ment of cells with cycloheximide (20/~M, 4 h) had no effect 
on the anti-CD29-rdated increase in tyrosine phosphoryla- 
tion of Fpl05 (data not shown). These results indicated that 
the immunoreactive 105-kD band present after crosslinking 
of the VLA antigens was due to an increase in its tyrosine 
phosphorylation, and not to an increase in its protein syn- 
thesis. Thus, our results suggested that the crosslinking of 
VLA antigens with anti-CD29 could increase tyrosine phos- 
phorylation of ppl05 in the H9 T  cell line. 
VLA-4 Is Involved in the Induction of ppl05  Tyrosine Phos- 
phorylation in H9 Cells.  To clarify which of the VLA pro- 
teins is involved in the tyrosine phosphorylation of ppl05, 
we performed the  same  crosslinking studies using mAbs 
specific for each of the VLA-ot chains. Immunofluorescence 
analysis revealed that H9 cells expressed VLA-3 (40.1%), -4 
(99.1%),  -5  (22.2%),  and -6 (78.2%),  and the expression 
of VLA-1 and -2 were minimal (7.8%,  and 0.6%,  respec- 
tively;  data not shown). However,  as shown in Fig.  4,  of 
the  6  different  VLA  c~  chain-specific  antibodies,  only 
anti-VLA-4 (8F2) could increase tyrosine phosphorylation on 
Figure 1.  Crosslinking VLA molecules with anti-VLA-~/1 (anti-CD29) 
stimulates  tyrosine phosphorylation  of ppl05 in H9 cells. H9 cells were 
treated  for the time  indicated (min) with anti-CD29 (4B4, 10/~g/ml), 
and crosslinked with anti-mouse Ig. Proteins phosphorylated  on tyrosine 
residues were detected by immunoblot analysis using t~l-labeled c~IrF an- 
tibody (4G10). 
Figure 2.  Induction of ppl05 tyrosine phosphoryhtion is specific for 
anti-CD29.  H9 cells were incubated  with medium (hne 1), anti-CD29 
(10 ~g/ml, lane 2), anti-LPA-1 (10/zg/ml, lane 3), anti-MHC class I (10 
~g/ml, lane 4), and anti-CD45 (10 ~ag/rnl, hne 5), followed by crosslinking 
with anti-mouse Ig for 10 min at 37~  H9 cells were also treated with 
anti-VLA-B1 alone without crosslinking by anti-mouse lg (lane 6). The 
tyrosine phosphorylation of ppl05 was detected by aPT immunoblotting. 
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but not by phosphoserine or phosphothreonine.  Cell lysates from untreated 
(-) or anti-CD29-treated (anti-CD29) H9 cells were separated on 7.5% 
SDS-PAGE,  electrotransferred to nitrocdhlose, and probed with  12sI- 
labeled oePT in the absence or presence of phosphotyrosine (p-Tyr), phos- 
phoserine (p-Ser), or phosphothreonine (p-Thr).  (B) Induction of ppl05 
tyrosine phosphoryhtion could be inhibited by genistein. H9 cells were 
pretreated with genistein at the indicated concentrations for 15 min at 
37~  in the presence of 1% DMSO, and then treated with anti-CD29 
crosslinking. Viability of H9 cells was not affected  over this range of genistein 
concentration, ppl05 in each cell lysate was detected by aPT immuno- 
blotting. 
ppl05 to a level comparable with that obtained using anti- 
CD29. None of the other anti-VLA-o~  mAbs had a significant 
effect. Although we cannot rule out the possibility that other 
VLA proteins expressed at the same levels as VLA-4 might 
also be capable of inducing tyrosine phosphorylation of ppl05, 
our results indicate that VLA-4is the primary molecule in- 
volved in triggering the tyrosine phosphorylation  of this mol- 
e~le in H9 cells. 
The CSI Alternatively Spliced Segment of FN Can also In- 
duce ppl05 Tyrosine Phosphorylation in 1-19 Cells.  Next, we 
examined whether a ligand for VLA-4 could also induce tyro- 
sine phosphorylation of ppl05. Although both VLA-4 and 
-5 were initially identified as receptors for FN, it has since 
been shown that they recognize and bind distinct regions 
of the FN molecule. VLA-4 recognizes the alternatively spliced 
CS1 segment of the FN molecule (34-36),  which is distinct 
Figure 4.  VLA-4 is the primary molecule involved in inducing tyrosine 
phosphoryhtinn of ppl05 in H9 cells. H9 cells were treated with medium 
alone (-) or mAbs reactive with VLA-131 and different  VLA-o~ chains 
crosslinked with anti-mouse or anti-rat Ig. Each cell lysate was subjected 
to SDS-PAGE and then blotted with 12sI-otPT. 
from the KGD call binding region recognized by VLAo5 (37, 
38). Therefore, we examined whether the interaction of VLA-4 
with its ligand, the CS1 region of FN, could induce ppl05 
tyrosine phosphorylation.  H9 cells specifically  bound to plates 
coated with a synthetic CS1 peptide/IgG conjugate, but not 
to uncoated ones, when they were cultured on these plates 
for 30  min (data  not  shown).  Under these  conditions,  a 
significant increase in the tyrosine phosphorylation of ppl05 
in cells from CSl-coated wells was observed (Fig.  5, lanes 
1 and 2). There was a less prominent increase  in tyrosine phos- 
phorylation of the shghtly higher band mentioned previously. 
Furthermore, the protein kinase C  activator  PMA, which 
is known to augment the binding of integrins to their ligands 
(5, 39), was found to upregulate the ppl05 tyrosine phos- 
phorylation induced by interaction with the CS1/IgG con- 
jugate (Fig. 5, lane 3). PMA alone had no effect (Fig. 5, lane 
4). Both the binding of H9 cells  to plates coated with CS1/IgG 
conjugate, and the induction of ppl05 tyrosine phosphoryla- 
tion were almost completely blocked by the addition of soluble 
anti-4B4 to the culture medium (Fig. 5, lane 5). These data 
indicate that the interaction between VLA-4 and its ligand 
(the CS1 domain of FN) can trigger the tyrosine phosphory- 
lation of ppl05 in H9 T  cells. 
Ligation of VLA-4 with anti-VLA-oz4 Antibody or with Its 
Ligand Can Induce Increased Tyrosine  Phosphorylation  of  ppI05 
in Peripheral  Resting T  Cells.  We next examined whether 
the ligation of VLA proteins  on peripheral  resting T  cells 
could stimulate tyrosine phosphorylation. As shown in Fig. 
6, crosslinking VLA molecules on resting T cells with anti- 
CD29  induced the tyrosine phosphorylation of a protein 
having the same molecular weight as ppl05 in H9 cells. Of 
six  different  anti-o~ chain  antibodies,  once  again,  only 
anti-VLA-4 was capable of inducing this response (Fig. 6 A). 
Moreover, the kinetics of phosphorylation obtained in resting 
Figure 5.  The binding of H9 
cells with the alternatively  spliced 
CS1 domain of FN induced tyro- 
sine phosphorylation of ppl05. 
H9 cells were cultured in wells 
coated with synthetic CS1 pep- 
tide-rabbit IgG conjugates (2.5 
nmol/ml, lanes 2, 3, and 5) or un- 
coated wells (lanes 1 and 4), in the 
presence of PMA (5 ng/ml, lanes 
3 and 4), or soluble anti-CD29 an- 
tibody (10 #g/m1, lane 5). After 
30  min,  cells  were  harvested, 
pelleted, and lysed with lysis  buffer 
containing  1%-NP-40.  Proteins 
phosphoryhted  on  tyrosine re- 
sidues were detected by aPT im- 
munoblotting. 
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also  stimulated  tyrosine  phosphorylation  of  ppl05.  (A) 
Anti-VLA-~I and anti-VLA-oe4,  but not mAbs against other 
VLA-~ chains stimulated tyrosine phosphorylation  of ppl05 
in resting T cells. (B) Kinetics of ppl05 tyrosine phosphory- 
lation  induced by anti-CD29 crosslinking.  Resting T  cells 
were incubated with anti-CD29, followed  by crosslinking with 
anti-mouse Ig for indicated periods (min).  (C) The binding 
of peripheral T  cells with the alternatively spliced CS1 do- 
main  of FN induced  increased tyrosine  phosphorylation  of 
ppl05. T cells were cultured  in wells coated with synthetic 
CS1 peptide-rabbit IgG conjugates (2.5 nmol/ml) or uncoated 
wells in the presence of PMA (2 ng/ml). After 60 min, cells 
were harvested, pelleted, and lysed with lysis buffer containing 
1%-NP-40. Proteins phosphorylated on tyrosine residues were 
detected by otvr immunoblotting. 
T  cells were exactly  the same as those in H9 cells (Fig.  6 
B). The same molecular mass, receptor specificity, and ki- 
netics of phosphorylation, all suggest that the crosslinking 
of VLA-4 results in phosphorylation of the same molecule 
in both peripheral T  cells and in the H9 cell line.  We also 
attempted to examine whether immobilized CSI-IgG con- 
jugates could induce ppl05 tyrosine phosphorylation in pe- 
ripheral T  cells. Since resting T  cells bound poorly to the 
CSI-IgG, we performed this experiment in the presence of 
PMA (2 ng/ml). A significant increase in tyrosine phosphory- 
lation of ppl05 could also be observed in T cells after their 
binding to the immobilized CSI-IgG (Fig.  6 C).  In addi- 
tion, increased tyrosine phosphorylation of the slightly higher 
band occurred, as seen occasionally  in H9 cells. Thus, the 
tyrosine phosphorylation of ppl05, after perturbation of the 
VLA-4 molecule, is not unique to the H9 cell line. 
Tyrosine Kinase Activation via the CD3/TCR  Pathway and 
the VLA-4 Molecule Are Independently Regulated.  Previously, 
we showed (10) that VLA-4 mediates CD3-dependent T cell 
proliferation through interaction with its ligand, the alter- 
natively spliced domain of FN (CS1). Since PTK activation 
has been shown to be an early event in T cell activation via 
the CD3/TCR pathway (14-23), we examined whether or 
not there was a relationship between the tyrosine kinase(s) 
activated by the CD3/TCK and VLA-4 pathways. We com- 
pared the proteins phosphorylated on tyrosine residues after 
treatment of H9  cell with anti-CD3  and anti-VLA-4.  As 
shown in Fig. 7 A, the two stimuli caused distinct patterns 
of increased protein tyrosine phosphorylation. In contrast to 
anti-VLA-4, which exclusively stimulated phosphorylation 
of ppl05 (lane 2), anti-CD3 induced the tyrosine phosphory- 
lation of several proteins with molecular masses of 140, 120, 
116, 95,  85, and 45 kD (lane 3).  In Fig.  7 B,  the relative 
amount of tyrosine phosphorylation of ppl05 (VLA-4-de- 
pendent) and pp116 (CD3-dependent) in H9 cells was graphed 
as a function of time after addition of each mAb. As already 
shown in Fig. 1, ppl05 tyrosine phosphorylation induced by 
anti-VLA-4 reached a maximal level at 5-10 rain, and per- 
sisted for at least 60 min after the initiation of stimulation 
with  a  slight  decline.  In  contrast,  the  maximal level  of 
anti-CD3-dependent ppl16 tyrosine phosphorylation was at- 
tained within 1 min. By the 5-min time point, the level of 
phosphorylation was beginning to decline,  and by 30 min 
it was near the basal levels. Similar  kinetics were also ob- 
served  for  the  tyrosine  phosphorylation of  other  CD3- 
dependent proteins, which is consistent with previous reports 
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the CD3/TCR  pathway and the VLA-4 
molecule are independently regulated. (/1) 
Crosslinking the CD3 molecule with anti- 
CD3 stimulated the tyrosine phosphoryla- 
tion of a different set of proteins in H9 cells 
from that (ppl05) stimulated after VLA-4 
crosslinking.  H9  cells  were  cultured  in 
medium alone (lane 1), or treated for 1 min 
by crosslinking with anti-VLA-4 (lane 2), 
anti-CD3 (lane 3), or anti-VLA-4 plus anti- 
CD3 (lane 4). (B) Kinetics of tyrosine phos- 
phorylation induced by anti-VLA-4- and 
anti-CD3 crosslinking. H9 cells were in- 
cubated  with  either  anti-CD3  or  anti- 
CD29,  followed  by  crosslinking  with 
anti-mouse Ig for the indicated time periods 
(min). The anti-CD3-induced increase in 
tyrosine phosphorylation of the  116-kD 
protein (O) and the anti-VLA-4-induced 
increase in tyrosine phosphorylation of the 
ppl05 (0) were quantitated by scanning the 
autoradiograms with a densitometer.  The 
peak heights are graphed as percent of max- 
imum value. 
(19, 20). Thus, the pattern and kinetics of tyrosine phosphory- 
lation  are completely different after anti-CD3 and -VLA-4 
crosslinking. Furthermore, when T cells were simultaneously 
treated with anti-CD3 and -VLA-4, the resultant phosphory- 
lation pattern was merely a sum of the bands obtained after 
stimulation with each antibody individually (Fig. 7 A, lane 
4).  No augmentation or reduction in the level of tyrosine 
phosphorylation of any of the bands was observed. The ki- 
netics were also unaffected when cells were stimulated with 
a combination of  both antibodies. Taken  together, these results 
strongly suggest that the tyrosine phosphorylation, triggered 
via the VLA-4 molecule, is independently regulated from that 
stimulated via the CD3/TCR pathway. This implies that dis- 
tinct tyrosine kinases might play a role in the signal trans- 
duction after ligand  occupancy of VLA-4 and the TCR. 
Discussion 
Although considerable progress has been made in defining 
the structure and function of the VLA antigens, very little 
is known about second signals generated after ligand binding. 
For example, the spreading of capillary endothelial cells on 
FN via integrin receptors (VLAo5) can induce intracellular 
alkalinization resulting from activation of a transmembranous 
Na +/H + antiporter (40). Another report (41) showed that 
a mAb directed against a specific  epitope of the V'LA-/$1 chain 
resulted in increased levels of intracellular cAMP in T cells 
stimulated by anti-CD3 or -CD2 mAb, thereby inhibiting 
T  cell proliferation by these stimuli.  However, the mecha- 
nism underlying these responses are still far from clear. In 
this  paper, we have demonstrated that engagement of the 
VLA-4 molecule  by specific antibodies, or by the CS1 region 
of FN, rapidly stimulates tyrosine phosphorylation on ppl05 
in resting T cells and in the H9 T cell line. Other VLA mol- 
ecules (VLA-1, -2, -3, -5, and -6) did not appear to be in- 
volved in this response. In addition,  the PTK activation in- 
duced by VLA-4 ligation was regulated independently from 
that induced by the CD3/TCR pathway. It is unclear why 
H9 cells are unique amongst the T cell lines tested for this 
signal transduction pathway. Either ppl05 itself, or a PTK(s) 
responsible for its phosphorylation may be absent in other 
T cell  lines. However, the significance  of this pathway should 
be emphasized  by its activation after the perturbation of  VLA-4 
on normal peripheral T  cells. Although it still remains to 
be determined which P'rK(s) is involved  in this response, ppl05 
tyrosine phosphorylation appears to be a specific and early 
signal transmitted after the interaction  of VLA-4 with ex- 
ternal  stimuli. 
Since neither the/31 nor or4 subunits  of the VLA-4 pro- 
tein have inherent PTK activity, our data suggest that the 
VLA-4 receptor must be functionally or physically linked 
with a PTK(s).  A putative  role for PTKs in cell adhesion 
has been described in the past (24-27).  An earlier report by 
Rohrschneider  (24) showed that the src oncogene product, 
pp60  ..... ,  which is  a tyrosine kinase,  was concentrated in 
adhesion  plaques of RSV-transformed  cells. The adhesion 
plaque is a specialized structure for cell-to-cell and cell-to- 
ECM contact. Its constituent elements, including FN receptors 
(integrin),  talin, and vinculin, were found to be hyperphos- 
phorylated on tyrosine residues in these transformed cells. 
The PTK activation found in these cells was presumed to 
be closely associated with the transformed phenotype (25). 
Tsukita  et  al.  (27) have also recently shown that  proto- 
oncogenic tyrosine kinases such as c-yes,  c-src,  and c-lyn,  are 
enriched in cell-cell adherence  junctions in normal adult tissues 
where the level of tyrosine phosphorylation is also elevated. 
Thus, PTKs may be physically associated  with adhesion mol- 
ecules in both transformed and normal cells, and may con- 
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riety of biological consequences.  Our present report is the 
first demonstration that the ligation of VLA molecules on 
T  cells is functionally associated with PTK activation. 
Thus far, we have no evidence that VLA molecules other 
than VLA-4 are involved in PTK activation in T cells. It is 
especially interesting that ppl05 tyrosine phosphorylation was 
specific for the VLA-4 molecule, which is unique within the 
VLA antigen family. First, VLA-4 differs structurally from 
the other B1 integrins in that the or4 subunit is only weakly 
associated with its/81 subunit, and that the 150-kD o~4 pro- 
tein usually undergoes partial cleavage to form 80- and 70- 
kD  fragments (42).  Moreover,  a  180-kD  form of the or4 
subunit, which associates with/81, has also been identified 
(42). Second, the distribution of VLA-4 is relatively restricted 
to lymphoid and myeloid cells (2), and its expression is gener- 
ally low on most adherent cells (which express other VLA 
molecules at higher levels). Third, although VLA-4 mediates 
attachment of cells to ECM like other members of the/81 
integrin family (34-36), it is also involved in cell-to-cell in- 
teractions (43).  In addition to the alternatively  spliced CS1 
domain of FN, a second ligand has been identified for VLA-4 
(43).  This vascular cell adhesion molecule 1 (VCAM-1)  is 
a member of the Ig family, and is expressed on activated en- 
dothelial cells (44). In addition, the presence of a third ligand 
for the VLA-4 has been postulated. This ligand is proposed 
to function as a counter-receptor for VLA-4 on lymphocytes, 
and to mediate homotypic lymphocyte aggregation triggered 
by mAbs that recognize a distinct epitope within the VLA 
molecule (45, 46). Thus, VLA-4, through its multiple ligand 
specificity, may confer different functional effects on T cells 
(47). It is presently unknown whether interactions of VLA-4 
with its other ligand(s) result in ppl05 tyrosine phosphory- 
lation. However, we did observe that homotypic T cell aggre- 
gation, triggered by an anti-VLA-4 (HP2/4) antibody (kindly 
provided by Dr. Sanchez-Madrid,  Madrid, Spain),  resulted 
in an intense tyrosine phosphorylation of ppl05 (our unpub- 
lished observation). Using a soluble VCAM-1 fusion pro- 
tein,  Damle  and  Aruffo  (11) recently demonstrated that 
VCAM-1, like the CS1 domain of FN, could also transmit 
costimulatory activation signals with anti-CD3 to CD4 § T 
cells via VLA-4. It is possible that the ligation of VLA-4 by 
VCAM-1 may also induce ppl05 tyrosine phosphorylation 
in T cells. If true, ppl05 tyrosine phosphorylation may be 
a common biochemical event resulting from the ligation of 
the VLA-4 receptor with different ligands. 
Our present study showed that ppl05 tyrosine phosphory- 
lation was independently regulated from the PTK activation 
that follows TCR/CD3 ligation. Meanwhile, engagement 
of VLA receptors on T cells with anti-VLA-/81 did not stimu- 
late turnover of phosphoinositides and had no effect on the 
intracellular concentration of Ca  2+ (our unpublished obser- 
vations). Each of these signals is associated with signal trans- 
duction through the CD3/TCR complex (14-23).  We have 
shown in a previous report (48) that the engagement of the 
VLA molecule with FN induced the AP-1 transcriptional 
factor in an independent fashion from the TCR/CD3 pathway. 
The stimulation of the latter pathway (CD3/TCK) has been 
shown to induce another transcriptional factor, NFAT-1, which 
is felt to activate transcription of the I1.,2 gene in combina- 
tion with the AP-1 factor (49). In this manner, the CD3/TCR 
and the CD29/VLA receptor complexes appear to stimulate 
distinct but converging signal transduction pathways. How- 
ever, previous studies have shown that at least four distinct 
VLA molecules (VLA-3-6) can transmit similar costimula- 
tory signals for I1.-2 production and T cell proliferation (6-11). 
In this regard, it remains to be shown whether ppl05 tyro- 
sine phosphorylation is actually linked to the activation of 
I1.-2 gene transcription, or to the comitogenic proliferative 
signals observed after engagement of the VLA-4 molecule 
by its ligands (FN and VCAM-1).  Whether such signals de- 
livered to the cell via VLA-4 use other (unknown) transducing 
elements common to all VLA molecules is unclear. Further 
study of this point is underway. 
In summary, our findings strongly suggest that activation 
of a PTK, leading to tyrosine phosphorylation of ppl05, is 
one of the early steps in signal transduction through the VLA-4 
molecule on T cells. A recent report by Kornberg et al. (50), 
demonstrated increased tyrosine phosphorylation of a 130 kD 
protein induced by clustering of B1  integrins on human 
epidermal carcinoma (KB) cells. Therefore, tyrosine kinase 
activation after ligation of VLA molecules may be a common 
event found in a variety of cell types.  The nature of ppl05 
is presently unknown. It seems to be distinct from either 
the B1 subunit of VLA-4, or from vimentin, which have mo- 
lecular masses of around 100 and 130 kD, respectively, and 
can be tyrosine phosphorylated (24). This conclusion is based 
on immunoprecipitation  experiments where ppl05 could not 
be precipitated with antibodies directed against each of these 
proteins (data not shown). It has also been shown that ppl05 
differs from ppl00 or pp135 (19), substrates for CD3/TCR 
pathway-associated  PTKs.  Purification and/or gene cloning 
may be necessary for the ultimate determination of the na- 
ture and structure of ppl05.  Identification of the PTK(s) 
responsible for ppl05 tyrosine phosphorylation, and the role 
of PTK activation in VLA-mediated effects on cell function 
will be the objects of future investigation. These efforts should 
shed more light on the molecular mechanisms of signal trans- 
duction via VLA molecules. 
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